| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/15/1997 | EP0753062A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 01/15/1997 | EP0753008A1 Peptide vaccines and methods relating thereto |
| 01/15/1997 | EP0753006A1 Vpr AND Vpx PROTEINS OF HIV |
| 01/15/1997 | EP0753005A1 Cytotoxic t-cell lymphocyte ("ctl") activity regulation by class i mhc peptides |
| 01/15/1997 | EP0752991A1 INDENO[1,2-e]PYRAZINE-4-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 01/15/1997 | EP0752990A1 Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis |
| 01/15/1997 | EP0752987A1 Pyrimidinyl derivatives as interleukin inhibitors |
| 01/15/1997 | EP0752886A1 Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes |
| 01/15/1997 | EP0752884A1 Method of treating auto-immune diseases using type one interferons |
| 01/15/1997 | EP0752880A1 Treatment of autoimmune disease using oral tolerization and/or type i interferon |
| 01/15/1997 | EP0752879A1 TREATMENT OF AUTOIMMUNE DISEASE USING ORAL TOLERIZATION AND/OR Th2-ENHANCING CYTOKINES |
| 01/15/1997 | EP0752867A1 Selective cell proliferation |
| 01/15/1997 | EP0752864A1 Use of growth factor protecting polymers for treating inflammation |
| 01/15/1997 | EP0642332B1 Ophthalmic compositions containing a cyclosporin |
| 01/15/1997 | EP0584091B1 Benzopyranones, methods of manufacture and use thereof |
| 01/15/1997 | EP0495919B1 PROTECTION FROM SHOCK SUBSEQUENT TO INJURY BY DOUBLE-STRANDED RNAs |
| 01/15/1997 | EP0495831B1 Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction |
| 01/15/1997 | EP0440742B1 Liposome immunoadjuvants containing il-2 |
| 01/15/1997 | CN1140456A Superagonists and antagonists of H IL-6, and 3-D modelling method for their selection |
| 01/15/1997 | CN1140414A Use of anti-TNF antibodies as drugs in treating diseases involving elevated interleukin-6 serum levels |
| 01/15/1997 | CN1140413A Humanized antibodies against leukocyte adhesion molecule VLA-4 |
| 01/15/1997 | CN1140178A Use of new steroid compound for preparing medicaments |
| 01/15/1997 | CN1140173A Novel pyrido |3,2-e¨ pyrazinones with anti-asthmatic action and processes for their manufacture |
| 01/15/1997 | CN1140165A Arylsulfonyl hydroxamic acid derivatives |
| 01/15/1997 | CN1140059A Process for preparing pharmaceutical composition contg. new steroid compounds |
| 01/14/1997 | US5594154 5-amino-2-bromomethyl-2,4,6,7-tetramethyl-2,3-dihydrobenzo(b) furans |
| 01/14/1997 | US5594022 Carbamates |
| 01/14/1997 | US5593992 Cytokine inhibitors |
| 01/14/1997 | US5593991 Imidazole compounds, use and process of making |
| 01/14/1997 | US5593990 Methods and compositions for inhibition of angiogenesis |
| 01/14/1997 | US5593884 Oncoprotein protein kinase |
| 01/14/1997 | US5593877 Nucleic acid and recombinant production of vespid venom hyaluronidase |
| 01/14/1997 | US5593698 Immunosuppressants |
| 01/09/1997 | WO1997000959A1 Antigen non-specific glycosylation inhibiting factor derivatives |
| 01/09/1997 | WO1997000891A1 Methods for treatment and prevention of diabetes |
| 01/09/1997 | WO1997000860A1 Cb2 receptor agonist compounds |
| 01/09/1997 | WO1997000690A1 Interleukin-1 receptor-associated protein kinase and assays |
| 01/09/1997 | WO1996039511A3 A c5a-like seven transmembrane receptor |
| 01/09/1997 | CA2225406A1 Methods for treatment and prevention of diabetes |
| 01/09/1997 | CA2225379A1 Cb2 receptor agonist compounds |
| 01/09/1997 | CA2224995A1 Antigen non-specific glycosylation inhibiting factor derivatives |
| 01/08/1997 | EP0752005A1 Compacted nucleic acids and their delivery to cells |
| 01/08/1997 | EP0751957A1 Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases |
| 01/08/1997 | EP0751932A1 Vitamin-d amide derivatives |
| 01/08/1997 | EP0751780A1 Methods of isolating cd1-presented antigens, vaccines comprising cd1-presented antigens, and cell lines for use in said methods |
| 01/08/1997 | EP0751709A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 01/08/1997 | EP0668863B1 Quinuclidine derivative as substance p antagonist |
| 01/08/1997 | EP0558657B1 Retroviral protease inhibitors |
| 01/08/1997 | EP0469075B1 Use of lipoxin a 4? and its derivatives as antagonists for slow-reacting substances of anaphylaxis |
| 01/08/1997 | EP0341273B1 Biological materials, processes for producing biological materials and for using such materials in therapy |
| 01/08/1997 | EP0268636B1 Polynucleotide sequences encoding the human FC RECEPTOR FOR IMMUNOGLOBULIN |
| 01/08/1997 | CN1139933A Interleukin-6 (iL-6) antagonists |
| 01/08/1997 | CN1139932A N-terminally chemically modified protein compositions and methods |
| 01/07/1997 | US5591835 Substituted lactose derivatives |
| 01/07/1997 | US5591827 Interleukin-6 receptor antagonists |
| 01/07/1997 | US5591823 Expression of specific immunogens using viral antigens |
| 01/07/1997 | US5591776 Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV |
| 01/07/1997 | US5591772 Dietary supplements |
| 01/07/1997 | US5591629 Monoclonal antibodies which promote central nervous system remyelination |
| 01/07/1997 | US5591441 Composition for nonspecific cellular immune stimulation |
| 01/07/1997 | CA2043715C Imidazonaphthyridine derivatives |
| 01/07/1997 | CA2033497C 3-aminopiperidine derivatives and related nitrogen containing heterocycles |
| 01/07/1997 | CA1338836C Endotoxin binding protein and uses thereof |
| 01/03/1997 | WO1997000270A1 Novel peptides for use in treatment of t-cell mediated cartilage destruction in autoimmune diseases |
| 01/03/1997 | WO1997000242A1 Novel vitamin d derivatives with c-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments |
| 01/03/1997 | WO1997000079A1 P-selectin ligands and related molecules and methods |
| 01/03/1997 | WO1997000078A1 Methods of preventing or treating allergies |
| 01/03/1997 | WO1997000063A2 Urocortin peptides |
| 01/03/1997 | CA2224625A1 P-selectin ligands and related molecules and methods |
| 01/03/1997 | CA2224440A1 New vitamin d derivatives with substituents at c-25, process for their production, intermediate products and use for the production of pharmaceutical agents |
| 01/03/1997 | CA2223792A1 Urocortin peptides |
| 01/03/1997 | CA2221981A1 Novel peptides for use in treatment of t-cell mediated cartilage destruction in autoimmune diseases |
| 01/02/1997 | EP0751221A1 Recombinant mistletoe lectin (rML) |
| 01/02/1997 | EP0751220A1 Highly purified protein, production and use thereof |
| 01/02/1997 | EP0751137A1 Oxaindene derivatives and a process for preparing them as well as medicaments containing them and the use of them |
| 01/02/1997 | EP0750679A1 Isolated, tyrosinase derived peptides and uses thereof |
| 01/02/1997 | EP0750668A1 NOVEL MUTEINS OF IFN-$g(b) |
| 01/02/1997 | EP0750636A1 Methods to diagnose and treat hiv-1 infection |
| 01/02/1997 | EP0750607A1 2-(aminoalkoxy)phenylalkylamines with antiinflammatory activity |
| 01/02/1997 | EP0750513A1 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
| 01/02/1997 | EP0750511A1 Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor |
| 01/02/1997 | EP0750509A1 Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases |
| 01/02/1997 | EP0750507A1 PROTEASOME REGULATION OF NF-$g(k)B ACTIVITY |
| 01/02/1997 | EP0750458A1 Terminal complement inhibitor fusion genes and proteins |
| 01/02/1997 | EP0564461B1 The use of antibodies to tnf or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor |
| 01/01/1997 | CN1139435A New ginkgolide derivatives and process for preparing them |
| 01/01/1997 | CN1139434A Diazabicyclic neurokinin antagonists |
| 01/01/1997 | CN1139432A Prodrugs of inhibitor of HIV protease |
| 01/01/1997 | CN1139384A Use of mometasone furoate for treating airway passage and lung diseases |
| 12/31/1996 | US5589582 Polynucleotides en coding porcine cytokines |
| 12/31/1996 | US5589510 Method for inhibiting retroviral infection by administering a naphthalenesulfonic acid compound |
| 12/31/1996 | US5589508 Use of an emulsion to prepare an intravensously administered medicament for treating skin diseases |
| 12/31/1996 | US5589487 Piperidine derivatives and process for their production |
| 12/31/1996 | US5589471 Vitamin D analogues containing a hydroxy or alkylated hydroxy group in the 20-position |
| 12/31/1996 | US5589458 Compounds that inhibit T cell proliferation and methods for using the same |
| 12/31/1996 | US5589371 Polypeptides and yeast expression vectors for culture |
| 12/28/1996 | CA2180029A1 Oxaindene derivatives and process for the preparation thereof |
| 12/27/1996 | WO1996041815A2 CONJUGATES OF αMSH WITH A FATTY ACID, PREPARATION METHOD THEREFOR, AND USE THEREOF AS A DRUG |
| 12/27/1996 | WO1996041807A1 Rapamycin derivatives |
| 12/27/1996 | WO1996041645A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations |